Location History:
- Cambridgeshire, GB (2015)
- Cambridge, GB (2011 - 2022)
Company Filing History:
Years Active: 2011-2022
Title: The Innovative Contributions of Roman Hovorka
Introduction
Roman Hovorka is a distinguished inventor based in Cambridge, GB. He has made significant strides in the field of medical technology, particularly in diabetes management. With a total of 7 patents to his name, Hovorka's work focuses on improving the safety and efficacy of insulin delivery systems.
Latest Patents
Hovorka's latest patents include groundbreaking innovations such as an integrated closed-loop medication delivery system with an error model and safety check. This closed-loop system for insulin infusion utilizes a model predictive control algorithm (MPC) to optimize insulin delivery overnight. The MPC is complemented by a glucose measurement error model derived from actual glucose sensor error data, which includes both sensor artifacts and persistent error components. The algorithm advises on insulin infusion every fifteen minutes, significantly reducing the incidence of severe and significant hypoglycemia during simulated overnight closed-loop control.
Another notable patent addresses methods for reducing false hypoglycemia alarm occurrences. This system employs model-based state estimation and variable-delayed threshold values to balance the risk of missing an actual hypoglycemic state against the presentation of alarms caused by artifacts from continuous glucose monitors.
Career Highlights
Throughout his career, Hovorka has worked with prominent organizations such as Cambridge Enterprise Limited and Abbott Diabetes Care Inc. His contributions have been pivotal in advancing diabetes care technologies, making them safer and more reliable for users.
Collaborations
Hovorka has collaborated with esteemed colleagues, including Malgorzata E Wilinska and Erwin Satrya Budiman. These partnerships have further enriched his research and development efforts in the field of diabetes management.
Conclusion
Roman Hovorka's innovative work in insulin delivery systems exemplifies the impact of technology on healthcare. His patents and collaborations continue to pave the way for safer diabetes management solutions.